检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

POSTER: MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study

Nizar J. Bahlis,Christy Samaras,Donna Reece,Michael Sebag,Jeffrey Matous,Jesús G. Berdeja,Jesse Shustik,Gary J. Schiller,Siddhartha Ganguly,Kevin Song, Christopher S. Seet,Mirelis Acosta-Rivera,Donald Quick, Bertrand Anz,Gustavo Fonseca, Hongjuan Liu, Christian Gentili,David S. Siegel

Clinical Lymphoma, Myeloma & Leukemia（2023）

引用 0|浏览2
暂无评分
关键词
refractory multiple myeloma,lenalidomide treatment,daratumumab,dexamethasone
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要